Navigation Links
New collaboration to develop treatments for liver disease
Date:9/7/2012

A new collaboration based at the University of Cambridge will aim to discover and develop new medicines to treat liver disease.

The partnership, between the University and global pharmaceutical company GlaxoSmithKline (GSK), will build upon the work of researchers who have identified a molecular mechanism that plays a major role in the life-threatening liver disease that develops in a population of patients with a particular mutant gene.

Alpha-1 antitrypsin (A1AT) deficiency is one of the most common genetic disorders in the UK, affecting approximately one in 2,000 people. The A1AT protein is produced mainly in the liver and circulates to the lungs, where it serves a protective function against enzymes which can break down lung tissue.

In patients with A1AT deficiency, the protein cannot circulate freely and accumulates in the liver, leading to potentially life-threatening liver conditions including neonatal hepatitis, cirrhosis and hepatocellular carcinoma. Additionally, without A1AT circulating to the lungs, lung tissue can break down, predisposing patients to early onset emphysema. Currently, the only available treatments are liver transplantation for cirrhosis and protein replacement therapy for emphysema.

The mechanism that underlies protein accumulation in the livers of individuals with A1AT deficiency has been defined by the team led by Professor David Lomas in the University's Cambridge Institute for Medical Research (CIMR). The collaboration with GSK will combine Professor Lomas' long-term research with GSK's expertise in drug discovery and development in order to develop new therapeutics. Work on the project will be carried out both at GSK and at the CIMR.

"Currently, the only option for patients with liver disease as a result of alpha-1 antitrypsin deficiency is transplantation," said Professor Lomas. "This partnership brings together our collective expertise in target biology and drug discovery to tackl
'/>"/>

Contact: Sarah Collins
sarah.collins@enterprise.cam.ac.uk
44-122-376-0335
Cambridge Enteprise University of Cambridge
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Mayo Clinic, Dartmouth-Hitchcock announce collaboration
2. Treating the whole person with autism sets direction for parent-clinician collaboration
3. Astex, CRT and the Institute of Cancer Research announce epigenetic drug discovery collaboration
4. Researchers develop a new cell and animal model of inflammatory breast cancer
5. Scientist awarded $1 million grant to develop tools for hepatitis C treatment discovery
6. 2 genetic deletions in human genome linked to the development of aggressive prostate cancer
7. Kudos for 3 NJIT Enterprise Development Center high-tech companies
8. Study: Women not getting enough exercise; at risk of developing metabolic syndrome
9. Online Tool Could Diagnose Autism Quickly, Developers Say
10. Discovery could help to develop drugs for organ transplant and cancer patients
11. 2 repressor genes identified as essential for placental development
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... Top Northridge dentist , Dr. Farshid Ariz, is ... new dentist can be an intimidating experience. Many people struggle ... and worry about how they will connect with a new ... concerns and dental needs and works to ensure that each ... special coupon can help patients get the treatments they need ...
(Date:7/28/2014)... Pittsburgh, PA (PRWEB) July 28, 2014 "I ... slings were ineffective," said an inventor from Sunnyvale, Calif. "When ... The slings on the market are cumbersome and require too ... alternative." , She developed the Multiple Functioning Vest to improve ... shoulder and arm so that they heal properly. This helps ...
(Date:7/28/2014)... HealthDay Reporter FRIDAY, July 25, ... insurance this year will face fines of up to $2,448 ... Internal Revenue Service says. The Obama administration on Thursday ... some Americans will owe for failing to have health insurance. ... national average premium for a bronze-level health plan. ...
(Date:7/28/2014)... Glidewell Laboratories announced today that ... passed the five-year mark in clinical usage, and have ... prescribed by US dentists. , Even as BruxZir Solid ... results from respected clinical studies, many dentists expressed the ... extended years of clinical service before they would elect ...
(Date:7/28/2014)... 2014 Scientists in Japan have completed ... blood test for the asbestos cancer mesothelioma. Surviving Mesothelioma ... Click here to read it now. , ... Juntendo University Graduate School of Medicine say a new ... step above the old test. , “Particularly for ...
Breaking Medicine News(10 mins):Health News:Northridge Dentist, Dr. Farshid Ariz, is Now Offering a $100 Coupon for New Patients 2Health News:IRS Caps Fines on Uninsured Americans at $12K for Family of 5 2Health News:BruxZir® Solid Zirconia Surpasses Five Years of Clinical Use 2Health News:Test Results Look Promising for New Mesothelioma Blood Test, According to Surviving Mesothelioma 2
... Dec. 17 PureCart Systems LLC, announces,the launch of ... system for healthcare facilities. The system, which can ... equipment, patient beds and,rooms, provides a one-step, hospital-grade disinfectant ... require wiping or rinsing. , ...
... 17 EyeScience Labs announces the,availability of its advanced ... eye syndrome at CVS Pharmacy stores ( www.cvs.com ),nationwide. ... http://www.newscom.com/cgi-bin/prnh/20081217/CLW029-a ) , ... This marks the first time EyeScience Macular ...
... Imbach, Former Vice-President of Revenue and Customer Operations at LinkedIn Named ... Design at Yahoo! Named Product Fellow , ... Mountain ... the industry leader in personal genetics , announced today that ...
... receptor controls blood pressure, study shows , , WEDNESDAY, Dec. ... individuals tend to have high blood pressure, but now ... explain that link. , In findings published in the ... Journal of Medicine , Sadaf Farooqi, of the University ...
... In study, those with pulmonary clots saw benefit, , , ... that giving the clot-dissolving drug tenecteplase (TKNase) to people ... the drug, a form of tissue plasminogen activator (tPA), ... haven,t given up on the idea. , "In specific ...
... woman,s face, physicians say , , WEDNESDAY, Dec. 17 (HealthDay ... has completed the nation,s first near-total face transplant. , ... 80 percent of the skin surface of her face, ... essentially everything except the upper eyelids, forehead, lower ...
Cached Medicine News:Health News:PureCart Systems LLC Develops a Portable Disinfecting System for the Healthcare Industry 2Health News:EyeScience's New Ocular Nutrition Supplements Available at CVS Stores 2Health News:Silicon Valley Veterans Sarah Imbach and Larry Tesler Join 23andMe Management Team 2Health News:Silicon Valley Veterans Sarah Imbach and Larry Tesler Join 23andMe Management Team 3Health News:Silicon Valley Veterans Sarah Imbach and Larry Tesler Join 23andMe Management Team 4Health News:Study Finds Molecular Link Between Obesity, Hypertension 2Health News:Study Finds Molecular Link Between Obesity, Hypertension 3Health News:Clot Dissolver Doesn't Boost Survival in Cardiac Arrest Patients 2Health News:Clot Dissolver Doesn't Boost Survival in Cardiac Arrest Patients 3Health News:Doctors Describe First U.S. Face Transplant 2Health News:Doctors Describe First U.S. Face Transplant 3Health News:Doctors Describe First U.S. Face Transplant 4
(Date:7/25/2014)... "Australia Capsule Endoscopy Systems Market Outlook to 2020″, provides ... market. The report provides value, in millions of US ... dollars) within market segments: Photo - ... , Capsule Endoscopy Data Recorders , Capsule Endoscopy ... shares and distribution shares data for each of these ...
(Date:7/25/2014)... 25, 2014  Smile Train and its technology partner ... Virtual Surgery Simulator among leading global health innovations in ... in Washington, D.C. at The ... "Smile Train is honored to be represented ... of innovators in health and medicine that TEDMED unites ...
(Date:7/25/2014)... COSTA MESA, Calif. , July 25, 2014 /PRNewswire-iReach/ ... Peter Nieto as the new Vice President ... industry for over 30 years in a number of ... CROs in the industry. These positions were primarily related ... has obtained over the past 30 years makes him ...
Breaking Medicine Technology:Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 2Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 3Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 4Australia Capsule Endoscopy Systems Market Analysis and Forecast to 2020 5Smile Train and BioDigital Selected to Showcase Virtual Surgery Simulator in The Hive at TEDMED 2014 2Smile Train and BioDigital Selected to Showcase Virtual Surgery Simulator in The Hive at TEDMED 2014 3Contract Research Organization WCCT Global Welcomes Peter Nieto as Vice President of Business Development 2
The large External Fixator consists of rods, clamps, and pins. It has multiple external fixation frames, independent pin placement, and MR safe clamps. The modular frame construction permits fracture...
The DFS Standard Fixator advantages include a highly adjustable system, modular compression/distraction, versatile central body component that provides 360 of rotation, and a positive locking mechani...
For radial/ulnar translation, angulation, dorsal/volar translation, and incremental longitudinal distraction, this advanced system is appropriate when incremental adjustment provides an adjunctive me...
This radiolucent One-piece fixator permits independent mechanical adjustments of the following: Distraction/Compression, Dorsal/Palmar Translation, Radial/Ulnar Translation, Flexion/Extension....
Medicine Products: